Now US-based Merck wants to see if it can get Hanmi’s drug, known as efinopegdutide, to work in NASH after J&J walked away from developing it in obesity. Metabolic diseases is already a focus ...

Here are three stocks with buy rank and strong income characteristics for investors to consider today, March 28: Alexander's, ...

Roche’s Genentech unit is to partner with South Korea’s Hanmi Pharmaceutical, to develop and market a phase 1 cancer drug, in a deal potentially worth over $900 million. Under the agreement ...

Hanmi Financial (HAFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). As U.S. markets show signs of ...

Hanmi Semiconductor has increased the price of its thermal compression bonder (TC Bonder; TCB), a critical piece of equipment for high-bandwidth memory (HBM) production, by 25% starting April 1.

SEOUL, South Korea, April 2, 2025 /PRNewswire/ -- Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile ...

Hanmi joins with Federal Home Loan Bank of San Francisco to donate $30,000 each to the YMCA of Los Angeles and the Korean American Federation of Los Angeles LOS ANGELES, Feb. 12, 2025 (GLOBE ...

Hanmi Financial Trading Down 0.5 % NASDAQ:HAFC opened at $22.54 on Wednesday. The company has a market capitalization of $680.62 million, a PE ratio of 11.00 and a beta of 0.87. Hanmi Financial Co ...

SEOUL, South Korea, April 2, 2025 /PRNewswire/ -- Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile ...